ADVERTISEMENT

International

GOP Hill Staffer Joins US FDA As Senior Advisor, But Competing With MAHA For Legislative Position

Industry likely wants Grace Graham to take the FDA’s top policy and legislative role, but she may be passed over for someone more tied to HHS Secretary Robert F. Kennedy Jr.’s interests.

US Supplement Industry Needs Relief From ‘Drug Preclusion’ Policy, CRN Reminds FDA

CRN petition argues against general preclusion while NPA petition addressed specifically FDA’s wielding of the provision to prohibit the use of NMN supplements available in US. “FDA has acknowledged that they really can't answer one without answering. The two are inextricably linked,” says CRN CEO Steve Mister.

Makary US FDA Nomination Advances, Last Minute Hiccup May Offer Clues On Mifepristone

President Trump’s CDC director nominee was pulled after vaccine positions appeared too extreme for some Republicans, but the nominations to lead the FDA and NIH advanced to the Senate floor despite last-minute drama.

ChromaDex Changing Name To Niagen Bioscience While Shifting Focus To Rx NAD+

A week after announcing 2024 full-year and fourth-quarter results, the firm says its corporate name will be Niagen Bioscience Inc. starting 19 March. It stated in its latest results that during 2024 it launched Niagen Plus line of pharmaceutical-grade Niagen.

Eisai Still Considering Next Steps After Australia Again Rejects Alzheimer’s Drug Leqembi

The Australian Therapeutic Goods Administration proposed a narrower indication that Eisai rejected.

US Consumer Health Market Executive Moves: Vitamin Angels, Scholl’s Wellness, Prinova

Veteran pharma executive leads Vitamin Angels; CEO change to lead unifying Dr. Scholl's brand worldwide; and first CEO change for Prinova in 42 years.

Xlear Sees Tip Of FTC Policy Iceberg In DoJ Dismissal Of False Advertising Complaint

It wasn’t a quick decision for Xlear to accept DoJ attorneys’ offer to dismiss the case. “I want the I want the FTC to change its policy and its behaviors,” says Xlear president Nathan Jones.

US FDA May Lose Some Autonomy Under HHS General Counsel Reorganization

Health and Human Services Secretary Robert F. Kennedy Jr. is moving FDA Chief Counsel Robert Foster to a new senior position as Chief Counsel for Food, Research, and Drugs at HHS. Hilary Perkins will become FDA chief counsel.

Herbalife Spends To Add Personalized Supplements Through Nutrition App, Enter Ketone Market

Direct seller has deals to fully acquire and 51% ownership of Link BioSciences, which formulates personalized supplements. It also announced a deal to acquire Pruvit Ventures, ketone supplements direct seller.

HHS Secretary Kennedy Directs FDA To Consider Axing Self-Affirmed GRAS ‘Loophole’

Eliminating self-affirmation process would require companies to publicly notify FDA of their intended use of ingredients and provide safety data before they’re introduced. Kennedy says the process is “a loophole” for introducing ingredients and chemicals “with unknown safety data.”